medroxyprogesterone acetate has been researched along with AIDS Seroconversion in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, S; Brill, I; Chomba, E; Haddad, LB; Kilembe, W; Sharkey, T; Tichacek, A; Tote, K; Vwailika, B; Wall, KM | 1 |
Baeten, JM; Jaoko, W; Lavreys, L; Mandaliya, K; Martin, HL; McClelland, RS; Overbaugh, J; Richardson, BA; Sabo, MC | 1 |
Abbai, N; Boodhram, R; Moodley, D; Ramjee, G | 1 |
Hills-Nieminen, C; Tseng, A | 1 |
Chen, PL; Chipato, T; Doncel, GF; Fichorova, RN; Kwok, C; Mauck, C; Morrison, C; Salata, R | 1 |
Blanchard, K; Chipato, T; Harper, CC; Nhemachena, T; Ramjee, G | 1 |
Ahmed, K; Chen, PL; Friedland, B; Gehret-Plagianos, M; Kwok, C; Lahteenmaki, P; Morrison, CS; Patel, S; Ramjee, G; Skoler-Karpoff, S; van de Wijgert, J | 1 |
Jones, M | 1 |
Cohen, CR; Criniti, A; Meier, AS; Mwachari, CW; Nduba, V; Ngumo, JK; Sanguli, L | 1 |
Chohan, B; Kreiss, JK; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Overbaugh, J; Panteleeff, DD; Reilly, M; Wang, CC | 1 |
Baeten, JM; Chohan, V; Hassan, W; Kreiss, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Overbaugh, J | 1 |
Aberg, J; Aweeka, FT; Bardeguez, A; Coombs, RW; Lizak, P; Rosenkranz, SL; Segal, Y; Thevanayagam, L; Watts, DH | 1 |
Jackson, DJ; Kreiss, J; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA | 1 |
Ashley, RL; Bwayo, JJ; Corey, L; Kreiss, JK; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Richardson, BA; Wang, CC | 1 |
1 review(s) available for medroxyprogesterone acetate and AIDS Seroconversion
Article | Year |
---|---|
Drug interactions between antiretrovirals and hormonal contraceptives.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Seropositivity; Humans; Medroxyprogesterone Acetate; Nevirapine; Pregnancy; Pregnancy, Unplanned; Protease Inhibitors; Ritonavir | 2013 |
2 trial(s) available for medroxyprogesterone acetate and AIDS Seroconversion
Article | Year |
---|---|
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Contraceptives, Oral, Hormonal; Female; HIV Seropositivity; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Odds Ratio; Pregnancy; Proportional Hazards Models; Sexual Behavior; South Africa; Vaginal Creams, Foams, and Jellies; Young Adult | 2012 |
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Reverse Transcriptase Inhibitors; RNA, Viral; Sex Factors; Viral Load; Zidovudine | 2006 |
11 other study(ies) available for medroxyprogesterone acetate and AIDS Seroconversion
Article | Year |
---|---|
Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.
Topics: Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral, Hormonal; Female; HIV Seronegativity; HIV Seropositivity; Hormonal Contraception; Humans; Male; Medroxyprogesterone Acetate; Sexual Partners; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial; Zambia | 2019 |
Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.
Topics: Adult; Contraception; Contraceptives, Oral, Hormonal; Female; HIV Seropositivity; Humans; Kenya; Medroxyprogesterone Acetate; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Sex Workers; Vaginosis, Bacterial; Young Adult | 2019 |
Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
Topics: Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Pilot Projects; Progesterone; South Africa; Young Adult | 2019 |
Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
Topics: Adolescent; Adult; Case-Control Studies; Cervix Uteri; Chemokine CCL20; Chemokine CCL5; Contraceptive Agents, Female; Cytokines; Female; HIV Seropositivity; Humans; Immunity, Innate; Inflammation; Medroxyprogesterone Acetate; Pregnancy; Prospective Studies; Risk Factors; Secretory Leukocyte Peptidase Inhibitor; Uganda; Young Adult; Zimbabwe | 2014 |
Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.
Topics: Adult; Aged; Attitude of Health Personnel; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Directive Counseling; Evidence-Based Medicine; Family Planning Services; Female; Health Care Surveys; HIV Seropositivity; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Nurses'; Practice Patterns, Physicians'; Risk Factors; South Africa; Young Adult; Zimbabwe | 2014 |
Undiagnosed HIV in women attending a sexual health clinic for non-barrier methods of contraception. Two case studies.
Topics: Adult; AIDS Serodiagnosis; Ambulatory Care Facilities; Contraceptive Agents, Female; Diagnostic Tests, Routine; Family Planning Services; Female; HIV Seropositivity; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Reproductive Medicine; Safe Sex; United Kingdom | 2003 |
Association of hormonal contraception and HIV-seroprevalence in Nairobi, Kenya.
Topics: Adolescent; Adult; Age Distribution; CD4 Lymphocyte Count; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Female; HIV Seropositivity; Humans; Kenya; Medroxyprogesterone Acetate; Parity; Progesterone; Seroepidemiologic Studies | 2003 |
The effect of hormonal contraception on genital tract shedding of HIV-1.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptives, Oral, Hormonal; DNA, Viral; Female; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Medroxyprogesterone Acetate; Prospective Studies; RNA, Viral; Virus Shedding | 2004 |
Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women.
Topics: Adult; Chlamydia Infections; Contraceptives, Oral, Hormonal; Developing Countries; Female; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Injections, Intravenous; Kenya; Medroxyprogesterone Acetate; Proportional Hazards Models; Prospective Studies; Risk; Sex Work; Sexually Transmitted Diseases; Uterine Cervicitis | 2004 |
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.
Topics: Behavior; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Contraceptive Devices; Demography; Female; HIV Seropositivity; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; Multivariate Analysis; Prospective Studies; Risk Factors; Sex Work; Sexually Transmitted Diseases; Ulcer; Vaginal Discharge; Vulvitis | 1998 |
A prospective study of hormonal contraceptive use and cervical shedding of herpes simplex virus in human immunodeficiency virus type 1-seropositive women.
Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Female; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Seropositivity; HIV-1; Humans; Medroxyprogesterone Acetate; Polymerase Chain Reaction; Prospective Studies | 2002 |